BLUE — bluebird bio Income Statement
0.000.00%
Last trade - 00:00
- $194.16m
- $19.87m
- $3.60m
- 47
- 25
- 19
- 21
2018 December 31st | R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 54.6 | 0 | 0 | 3.66 | 3.6 |
Cost of Revenue | |||||
Gross Profit | 53.7 | 0 | 0 | -35.2 | -6.48 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 627 | 563 | 559 | 595 | 291 |
Operating Profit | -572 | -563 | -559 | -591 | -287 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -555 | -556 | -560 | -562 | -266 |
Provision for Income Taxes | |||||
Net Income After Taxes | -556 | -555 | -561 | -563 | -267 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -556 | -790 | -619 | -819 | -267 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -556 | -790 | -619 | -819 | -267 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -10.7 | -10.1 | -9.02 | -7.92 | -4.2 |